We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+1.91%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
+$101M
Cap. Flow
+$158M
Cap. Flow %
1.07%
Top 10 Hldgs %
22.11%
Holding
946
New
64
Increased
332
Reduced
304
Closed
69

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$57.5M
2
AZN icon
AstraZeneca
AZN
+$44.9M
3
ADSK icon
Autodesk
ADSK
+$43.5M
4
MELI icon
Mercado Libre
MELI
+$40.7M
5
AMGN icon
Amgen
AMGN
+$33.6M

Sector Composition

Rank Sector Weight
1 Healthcare 32.09%
2 Technology 24.53%
3 Financials 9.08%
4 Communication Services 8.24%
5 Consumer Discretionary 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OXY icon
601
Occidental Petroleum
OXY
$55.7B
$1.64M 0.01%
55,431
+5,010
+10% +$134K
ADM icon
602
Archer Daniels Midland
ADM
$38.7B
$1.64M 0.01%
27,293
+1,985
+8% +$119K
CHGG icon
603
Chegg
CHGG
$116M
$1.62M 0.01%
+23,867
New +$1.94M
UGI icon
604
UGI
UGI
$7.87B
$1.6M 0.01%
37,599
UL icon
605
Unilever
UL
$142B
$1.59M 0.01%
26,124
-29,595
-53% -$1.89M
VMC icon
606
Vulcan Materials
VMC
$36.8B
$1.59M 0.01%
9,390
+175
+2% +$31.3K
B
607
Barrick Mining
B
$60.9B
$1.56M 0.01%
86,625
+347
+0.4% +$6.97K
ESS icon
608
Essex Property Trust
ESS
$19.1B
$1.55M 0.01%
4,842
-360
-7% -$116K
CCL icon
609
Carnival Corporation Ltd
CCL
$38.1B
$1.53M 0.01%
61,008
+12,218
+25% +$284K
BKR icon
610
Baker Hughes
BKR
$58.3B
$1.52M 0.01%
61,436
+7,174
+13% +$160K
DOC icon
611
Healthpeak Properties
DOC
$15.5B
$1.51M 0.01%
45,088
-189,373
-81% -$6.7M
UBER icon
612
Uber
UBER
$145B
$1.51M 0.01%
33,657
+4,970
+17% +$217K
PARA
613
DELISTED
Paramount Global Class B
PARA
$1.49M 0.01%
37,607
+10,507
+39% +$428K
PTGX icon
614
Protagonist Therapeutics
PTGX
$8.55B
$1.48M 0.01%
83,646
EG icon
615
Everest Group
EG
$15.6B
$1.48M 0.01%
5,891
-505
-8% -$130K
OMC icon
616
Omnicom Group
OMC
$23.5B
$1.47M 0.01%
20,338
-3,537
-15% -$263K
PDD icon
617
Pinduoduo
PDD
$126B
$1.46M 0.01%
16,149
-322,594
-95% -$31.4M
EXPD icon
618
Expeditors International
EXPD
$22.3B
$1.46M 0.01%
12,244
-1,041
-8% -$130K
CP icon
619
Canadian Pacific Kansas City
CP
$81B
$1.45M 0.01%
22,203
+4,613
+26% +$329K
SWKS icon
620
Skyworks Solutions
SWKS
$9.2B
$1.45M 0.01%
8,781
VRSN icon
621
VeriSign
VRSN
$26.3B
$1.45M 0.01%
7,060
CAG icon
622
Conagra Brands
CAG
$7.42B
$1.43M 0.01%
42,336
+3,449
+9% +$117K
BF.B icon
623
Brown-Forman Class B
BF.B
$13.5B
$1.43M 0.01%
21,335
-1,697
-7% -$120K
VG
624
CALL
DELISTED
Vonage Holdings Corporation
VG
$1.43M 0.01%
+7,570,000
New +$110M
O icon
625
Realty Income
O
$61.1B
$1.42M 0.01%
22,602
-2,335
-9% -$158K

Similar funds

Candriam SCA's Q3 2021 Portfolio in Review

As of Q3 2021, Candriam SCA held 946 positions worth $14.7B, up 0.69% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA's Q3 2021 filing shows 64 new, 332 increased, 304 reduced and 69 closed positions. Its largest new stake was FIVE9: 86,075 shares worth $13.7M. The largest sale was Alexion Pharmaceuticals, an estimated $92.5M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q3 2021 buy was FIVE9: 86,075 shares worth $13.7M.
  • Candriam SCA added most to Johnson & Johnson in Q3 2021, an estimated $57.5M increase.
  • Candriam SCA's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $88M.
  • Candriam SCA fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $92.5M.
  • Candriam SCA's ten largest holdings make up 22% of its $14.7B portfolio in Q3 2021.
  • Candriam SCA opened 64 new positions and closed 69 in Q3 2021.
  • Candriam SCA's portfolio value rose 0.69% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q3 2021, filed 9 Nov 2021.